b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="nar" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2582611/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>A sensitive array-based assay for identifying multiple TMPRSS2:ERG fusion gene variants</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582611/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Nucleic Acids Research" /><meta name="citation_title" content="A sensitive array-based assay for identifying multiple TMPRSS2:ERG fusion gene variants" /><meta name="citation_authors" content="Qing Lu, Esperanza Nunez, Chunrun Lin, Kimberly Christensen, Tracy Downs, Dennis A. Carson, Jessica Wang-Rodriguez, Yu-Tsueng Liu" /><meta name="citation_date" content="November 2008" /><meta name="citation_issue" content="20" /><meta name="citation_volume" content="36" /><meta name="citation_firstpage" content="e130" /><meta name="citation_doi" content="10.1093/nar/gkn585" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2582611/?report=abstract" /><meta name="citation_pmid" content="18794177" /><meta name="DC.Title" content="A sensitive array-based assay for identifying multiple TMPRSS2:ERG fusion gene variants" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Oxford University Press" /><meta name="DC.Contributor" content="Qing Lu" /><meta name="DC.Contributor" content="Esperanza Nunez" /><meta name="DC.Contributor" content="Chunrun Lin" /><meta name="DC.Contributor" content="Kimberly Christensen" /><meta name="DC.Contributor" content="Tracy Downs" /><meta name="DC.Contributor" content="Dennis A. Carson" /><meta name="DC.Contributor" content="Jessica Wang-Rodriguez" /><meta name="DC.Contributor" content="Yu-Tsueng Liu" /><meta name="DC.Date" content="2008 Nov" /><meta name="DC.Identifier" content="10.1093/nar/gkn585" /><meta name="DC.Language" content="en" /><meta property="og:title" content="A sensitive array-based assay for identifying multiple TMPRSS2:ERG fusion gene variants" /><meta property="og:type" content="article" /><meta property="og:description" content="Studies of gene fusions in solid tumors are not as extensive as in hematological malignancies due to several technical and analytical problems associated with tumor heterogeneity. Nevertheless, there is a growing interest in the role of fusion genes in ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582611/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-nar.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2582611/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2582611/pdf/gkn585.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1A776BE99AA3E10000000007AA07A8.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/4/">Nucleic Acids Res</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/173577/">v.36(20); 2008 Nov</a></li><li class="accid">PMC2582611</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/narlogo.gif" alt="Logo of nar" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher\'s site" title="Link to Publisher\'s site" shape="default" coords="0,0,499,74" href="http://academic.oup.com/nar" target="pmc_ext" ref="reftype=publisher&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> </div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">Nucleic Acids Res</span>. 2008 Nov; 36(20): e130. </span></div><div><span class="fm-vol-iss-date">Published online 2008 Sep 15. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1093%2Fnar%2Fgkn585" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1093/nar/gkn585</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2582611</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/18794177">18794177</a></div></div></div></div><h1 class="content-title">A sensitive array-based assay for identifying multiple TMPRSS2:ERG fusion gene variants</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Lu%20Q%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18794177" class="affpopup" co-rid="_co_idm140160331065360" co-class="co-affbox">Qing Lu</a>,<sup>1</sup> <a href="/pubmed/?term=Nunez%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18794177" class="affpopup" co-rid="_co_idm140160337220064" co-class="co-affbox">Esperanza Nunez</a>,<sup>2</sup> <a href="/pubmed/?term=Lin%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18794177" class="affpopup" co-rid="_co_idm140160363384272" co-class="co-affbox">Chunrun Lin</a>,<sup>2</sup> <a href="/pubmed/?term=Christensen%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18794177" class="affpopup" co-rid="_co_idm140160363382608" co-class="co-affbox">Kimberly Christensen</a>,<sup>3</sup> <a href="/pubmed/?term=Downs%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18794177" class="affpopup" co-rid="_co_idm140160343358032" co-class="co-affbox">Tracy Downs</a>,<sup>1,</sup><sup>4</sup> <a href="/pubmed/?term=Carson%20DA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18794177" class="affpopup" co-rid="_co_idm140160336524768" co-class="co-affbox">Dennis A. Carson</a>,<sup>1,</sup><sup>5</sup> <a href="/pubmed/?term=Wang-Rodriguez%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18794177" class="affpopup" co-rid="_co_idm140160396287072" co-class="co-affbox">Jessica Wang-Rodriguez</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1,</sup><sup>3</sup> and  <a href="/pubmed/?term=Liu%20YT%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18794177" class="affpopup" co-rid="_co_idm140160471448448" co-class="co-affbox">Yu-Tsueng Liu</a><sup>1,</sup><sup>5,</sup><sup>*</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140160331065360"><h3 class="no_margin">Qing Lu</h3><p><sup>1</sup>Moores Cancer Center, <sup>2</sup>Howard Hughes Medical Institute, <sup>3</sup>Department of Pathology, <sup>4</sup>Department of Surgery and <sup>5</sup>Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA</p><div>Find articles by <a href="/pubmed/?term=Lu%20Q%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18794177">Qing Lu</a></div></div><div id="_co_idm140160337220064"><h3 class="no_margin">Esperanza Nunez</h3><p><sup>1</sup>Moores Cancer Center, <sup>2</sup>Howard Hughes Medical Institute, <sup>3</sup>Department of Pathology, <sup>4</sup>Department of Surgery and <sup>5</sup>Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA</p><div>Find articles by <a href="/pubmed/?term=Nunez%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18794177">Esperanza Nunez</a></div></div><div id="_co_idm140160363384272"><h3 class="no_margin">Chunrun Lin</h3><p><sup>1</sup>Moores Cancer Center, <sup>2</sup>Howard Hughes Medical Institute, <sup>3</sup>Department of Pathology, <sup>4</sup>Department of Surgery and <sup>5</sup>Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA</p><div>Find articles by <a href="/pubmed/?term=Lin%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18794177">Chunrun Lin</a></div></div><div id="_co_idm140160363382608"><h3 class="no_margin">Kimberly Christensen</h3><p><sup>1</sup>Moores Cancer Center, <sup>2</sup>Howard Hughes Medical Institute, <sup>3</sup>Department of Pathology, <sup>4</sup>Department of Surgery and <sup>5</sup>Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA</p><div>Find articles by <a href="/pubmed/?term=Christensen%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18794177">Kimberly Christensen</a></div></div><div id="_co_idm140160343358032"><h3 class="no_margin">Tracy Downs</h3><p><sup>1</sup>Moores Cancer Center, <sup>2</sup>Howard Hughes Medical Institute, <sup>3</sup>Department of Pathology, <sup>4</sup>Department of Surgery and <sup>5</sup>Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA</p><div>Find articles by <a href="/pubmed/?term=Downs%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18794177">Tracy Downs</a></div></div><div id="_co_idm140160336524768"><h3 class="no_margin">Dennis A. Carson</h3><p><sup>1</sup>Moores Cancer Center, <sup>2</sup>Howard Hughes Medical Institute, <sup>3</sup>Department of Pathology, <sup>4</sup>Department of Surgery and <sup>5</sup>Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA</p><div>Find articles by <a href="/pubmed/?term=Carson%20DA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18794177">Dennis A. Carson</a></div></div><div id="_co_idm140160396287072"><h3 class="no_margin">Jessica Wang-Rodriguez</h3><p><sup>1</sup>Moores Cancer Center, <sup>2</sup>Howard Hughes Medical Institute, <sup>3</sup>Department of Pathology, <sup>4</sup>Department of Surgery and <sup>5</sup>Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA</p><div>Find articles by <a href="/pubmed/?term=Wang-Rodriguez%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18794177">Jessica Wang-Rodriguez</a></div></div><div id="_co_idm140160471448448"><h3 class="no_margin">Yu-Tsueng Liu</h3><p><sup>1</sup>Moores Cancer Center, <sup>2</sup>Howard Hughes Medical Institute, <sup>3</sup>Department of Pathology, <sup>4</sup>Department of Surgery and <sup>5</sup>Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA</p><div>Find articles by <a href="/pubmed/?term=Liu%20YT%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18794177">Yu-Tsueng Liu</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140160331494592_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140160331494592_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140160331494592_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140160331494592_ai" style="display:none"><div class="fm-affl" lang="en" id="AFF1"><sup>1</sup>Moores Cancer Center, <sup>2</sup>Howard Hughes Medical Institute, <sup>3</sup>Department of Pathology, <sup>4</sup>Department of Surgery and <sup>5</sup>Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div id="COR1">*To whom correspondence should be addressed. Tel: +1 858 534 9972; Fax: +1 858 534 5399; Email: <a href="mailto:dev@null" data-email="ude.dscu@uilty" class="oemail">ude.dscu@uilty</a></div><div id="idm140160396928128">Correspondence may also be addressed to Jessica Wang-Rodriguez. Tel: +1 858 642 3511; Fax: +1 858 642 3918; Email: <a href="mailto:dev@null" data-email="ude.dscu@zeugirdorwj" class="oemail">ude.dscu@zeugirdorwj</a></div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140160331494592_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2007 May 7; Revised 2008 Aug 25; Accepted 2008 Aug 26.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140160331494592_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; 2008 The Author(s)</div><div class="license half_rhythm">This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<a href="http://creativecommons.org/licenses/by-nc/2.0/uk/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by-nc/2.0/uk/</a>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2582611/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm140160402628880" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140160402628880title" style="text-transform: uppercase;">Abstract</h2><!--article-meta--><div><p id="__p1" class="p p-first-last">Studies of gene fusions in solid tumors are not as extensive as in hematological malignancies due to several technical and analytical problems associated with tumor heterogeneity. Nevertheless, there is a growing interest in the role of fusion genes in common epithelial tumors after the discovery of recurrent TMPRSS2:ETS fusions in prostate cancer. Among all of the reported fusion partners in the ETS gene family, TMPRSS2:ERG is the most prevalent one. Here, we present a simple and sensitive microarray-based assay that is able to simultaneously determine multiple fusion variants with a single RT&#x02013;PCR in impure RNA specimens. The assay detected TMPRSS2:ERG fusion transcripts with a detection sensitivity of <strong>&#x0003c;</strong>10 cells in the presence of more than 3000 times excess normal RNA, and in primary prostate tumors having no <strong>&#x0003e;</strong>1% of cancer cells. The ability to detect multiple transcript variants in a single assay is critically dependent on both the primer and probe designs. The assay should facilitate clinical and basic studies for fusion gene screening in clinical specimens, as it can be readily adapted to include multiple gene loci.</p></div></div><div id="__sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec1title" style="text-transform: uppercase;">INTRODUCTION</h2><p id="__p2" class="p p-first">Chromosome rearrangements are a characteristic feature of cancer. More than 350 gene fusions, as a consequence of chromosome aberrations, have been identified (<a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270313">1</a>). While gene fusions are common in hematological malignancies, their presence in solid tumors is not as well studied due to several technical and analytic problems related to tumor heterogeneity (<a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270305">1</a>). Only very limited gene fusion events were discovered in solid tumors, mostly in sarcomas, until the recent discovery of TMPRSS2:ETS fusion genes in prostate cancer (<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270299">2</a>). This finding has since changed the general view that gene fusions play only a minor role in the pathogenesis of epithelial tumors. Therefore, there is renewed interest in searching for fusion genes in solid tumors, due to their potential impact on basic research and clinical application as has been demonstrated in chronic myelogenous leukemia (CML) (<a href="#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270247">3</a>,<a href="#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270263">4</a>).</p><p id="__p3">The recurrent gene fusion event in prostate cancer involves an androgen controlled gene, TMPRSS2, and members (ERG, ETV1 and ETV4) of the ETS transcription factor family (<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270300">2</a>,<a href="#B5" rid="B5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270253">5</a>,<a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270274">6</a>). Among these fusion genes, TMPRSS2:ERG is the most prevalent and the only member detected in the majority of reports. This fusion transcript results from &#x0223c;3 Mb interstitial deletion between these two loci at chromosome 21q22. It was found in approximately half (15&#x02013;78%) of all prostate cancers (<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270314">2</a>,<a href="#B6" rid="B6 B7 B8 B9 B10 B11 B12 B13 B14 B15 B16 B17" class=" bibr popnode">6&#x02013;17</a>). As an androgen-related transcription factor controlling cell proliferation, TMPRSS2:ERG has been associated with disease pathogenesis and is a promising biomarker for prostate cancer progression, prognostication and early detection (<a href="#B18" rid="B18 B19 B20 B21" class=" bibr popnode">18&#x02013;21</a>). While the presence of TMPRSS2:ETS fusion genes is highly prostate cancer-specific, its significance as a prognostic biomarker is still controversial partly because many of the clinical studies have been relatively small scale. Therefore, it is important to develop a simple and robust assay for identifying various TMPRSS2:ETS and potential fusion genes in other solid tumors. However, this could be challenging due to high heterogeneity in prostate cancer and other solid tumors, compared to leukemias and lymphomas (<a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270258">22</a>).</p><p id="__p4">Several approaches that have been used previously for hematological malignancies have been applied to detect TMPRSS2:ERG exon fusion variants. These include fluorescent <em>in situ</em> hybridization (FISH) (<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270308">2</a>,<a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270278">12</a>,<a href="#B14" rid="B14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270301">14</a>,<a href="#B17" rid="B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270244">17</a>,<a href="#B23" rid="B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270290">23</a>), RT&#x02013;PCR and sequencing (<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270282">2</a>,<a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270277">7</a>,<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270291">9</a>,<a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270255">13</a>), quantitative PCR (qPCR) (<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270311">2</a>,<a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270275">8</a>,<a href="#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270303">24</a>) and array-based comparative genome hybridization (array CGH) (<a href="#B10" rid="B10 B11 B12" class=" bibr popnode">10&#x02013;12</a>). FISH may be the most commonly used method, but it has relatively low resolution, and therefore, cannot accurately determine different fusion variants. Array CGH has a higher resolution but is costly and often fails when there is normal cell contamination.</p><p id="__p5" class="p p-last">RT&#x02013;PCR and qPCR are relatively easy to perform. However, to assess multiple potential fusion variants requires multiple sets of primers and probes, and a corresponding large quantity of RNA templates. Moreover, sequencing RT&#x02013;PCR products is laborious and difficult to adapt in routine clinical laboratories. Here, we describe an exon array-based detection system, combined with a RT&#x02013;PCR reaction, that accurately determines multiple TMPRSS2:ERG fusion transcripts in specimens with only a minor population of tumor cells. The method adopts several features of the Virochip (<a href="#B25" rid="B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270251">25</a>) protocol to establish a specific, sensitive and semi-quantitative assay that is very useful for analyzing highly heterogeneous solid tumors.</p></div><div id="__sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec2title" style="text-transform: uppercase;">MATERIALS AND METHODS</h2><div id="__sec3" class="sec sec-first"><h3 id="__sec3title">RNA isolation</h3><p id="__p6" class="p p-first-last">The cell lines described in the article were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA) and cultured as recommended. Frozen unpurified prostate tissues were obtained during routine surgery, and classified pathologically by one of us. The total RNA was extracted with Trizol (Invitrogen, Carlsbad, CA, USA) following the manufacturer\'s instructions. The primary tumor samples were purified by Qiagen RNeasy mini kit (Qiagen, Valencia, CA, USA).</p></div><div id="__sec4" class="sec"><h3 id="__sec4title">Microarrays</h3><p id="__p7" class="p p-first-last">The exon and junction probes are 30-mer oligonucleotides synthesized by Integrated DNA Technologies (Coralville, IA, USA) or Illumina/Invitrogen (San Diego, CA, USA) and printed on poly-<span class="small-caps">l</span>-lysine slides at 50 &#x003bc;M along with Human Cot-1 DNA (Invitrogen), which is enriched for repetitive sequences, and herring sperm DNA (Promega, Madison, WI, USA), which was used as nonspecific control. The printing procedure has been described and essentially follows the manual of the DeRisi arrayer with silicon microcontact printing pins (Parallel Synthesis Technologies, Inc. Santa Clara, CA, USA) (<a href="#B25" rid="B25 B26 B27" class=" bibr popnode">25&#x02013;27</a>). Arrays were postprocessed with succinic anhydride-based method for blocking before hybridization as previously described (<a href="#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270293">27</a>). The protocols related to array printing and hybridization in this article generally can be found in the following link: <a href="http://cat.ucsf.edu/equipment/arrayer/index.html" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://cat.ucsf.edu/equipment/arrayer/index.html</a>.</p></div><div id="__sec5" class="sec"><h3 id="__sec5title">Probe labeling</h3><p id="__p8" class="p p-first">The RT&#x02013;PCR reaction was performed with an OneStep RT-PCR kit (Qiagen) essentially following the manufacturer\'s protocol, except that the final reaction volume was scaled down to 20 &#x003bc;l. The forward (GTT TCC CAG TCA CGA TCC AGG AGG CGG AGG CGG A) and reverse primers (GTT TCC CAG TCA CGA TCG GCG TTG TAG CTG GGG GTG AG) are located at exon 6 of ERG and exon 1 of TMPRSS2 respectively, as described (<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270280">2</a>,<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270283">9</a>). The 5&#x02032;-ends of both primers have the sequence of primer B (GTT TCC CAG TCA CGA TC) for the subsequent step of PCR labeling with a single primer B as described previously (<a href="#B25" rid="B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270248">25</a>).</p><p id="__p9" class="p p-last">The procedure is a modification of the previously reported &#x02018;Round ABC&#x02019; protocol (<a href="#B25" rid="B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270262">25</a>). Briefly, the RT&#x02013;PCR reaction was assembled at 4&#x000b0;C in a PCR workstation and transferred to a thermocycler with the block preheated to 50&#x000b0;C. The initial reverse transcription was performed at 50&#x000b0;C for 30 min and followed by 95&#x000b0;C for 15 min to activate HotStarTaq DNA polymerase as well as to inactivate the reverse transcriptases (Round A). The PCR conditions were 35 cycles at 92&#x000b0;C for 30 s, 55&#x000b0;C for 30 s and 68&#x000b0;C for 1.5 min with a final extension step at 68&#x000b0;C for 5 min (Round B). One microliter of unpurified product was subsequently used as a template for another 20 cycles of amplification to label the amplicons via a previously described &#x02018;Round C&#x02019; PCR protocol (94&#x000b0;C for 30 s, 40&#x000b0;C for 30 s, 50&#x000b0;C for 30 s and 72&#x000b0;C for 1 min) with primer B and a 4:1 mixture of aminoallyl dUTP (Ambion, Austin, TX, USA) and dTTP for probe labeling (<a href="#B25" rid="B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270307">25</a>). The labeled amplicons were purified with DNA Clean-up and Concentrator-5 columns (Zymo Research, Orange, CA, USA), eluted in 9 &#x003bc;l of sodium bicarbonate (pH 9.0) and coupled with 1 &#x003bc;l of DMSO dissolved Cy3 NHS esters (GE Healthcare, Piscataway, NJ, USA) for 30&#x02013;60 min. The Cy3-labeled amplicons were purified with DNA Clean-up and Concentrator-5 columns and eluted with 10 &#x003bc;l of 10 mM Tris&#x02013;HCl (pH 8.0). Then, the Cy3-labeled amplicons were diluted in water and combined with 3.6 &#x003bc;l of 20&#x000d7; SSC, 0.5 &#x003bc;l of HEPES (pH 7.0) and finally 0.5 &#x003bc;l of 10% SDS to reach final volume of 25 &#x003bc;l. The mixed solution was heated for 2 min at 95&#x000b0;C, cooled to room temperature and hybridized to the exon mapping arrays at 63&#x000b0;C overnight essentially as previously described (<a href="#B25" rid="B25 B26 B27" class=" bibr popnode">25&#x02013;27</a>). The hybridized arrays were washed and scanned with a GenePix 4000B scanner (Molecular Device, Sunnyvale, CA, USA) and analyzed by GenePix Pro 6.0 software.</p></div><div id="__sec6" class="sec sec-last"><h3 id="__sec6title">2D DNA-FISH</h3><p id="__p10" class="p p-first">Frozen prostate cancer samples were sectioned onto slides. Cell nuclei were isolated <em>in situ</em> with ice-cold cytoskeleton buffer (CSK: 300 mM sucrose, 100 mM NaCl, 10 mM PIPES, 3 mM MgCL<sub>2</sub>, 1 mM EGTA and 0.5% Triton X-100) (<a href="#B28" rid="B28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270265">28</a>). The slides were fixed by dipping in ice-cold methanol for 3 min, followed by ice-cold acetone. After air drying the slides, they were allowed to age for at least 1 week in ethanol.</p><p id="__p11" class="p p-last">DNA-FISH was carried out according to a method for single copy loci detection (<a href="#B28" rid="B28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270261">28</a>). The protocol was adapted with few modifications, using 50-mer oligonucleotides specific to the loci of interest and labeled with a desired hapten. Two probes were used for FISH for break-apart assay. A probe located at the promoter region of TMPRSS2 was labeled with biotin (Bio/GACTCCAGGAGCGCTCCCCAGAATCCCCTTCCTTAACCCAAACTCGAGCC). The other probe at exon 2 of ERG was labeled with 5&#x02032;-6-carboxyfluorescein (56FAM) (56FAM/GATCTTTGGAGACCCGAGGAAAGCCGTGTTGACCAAAAGCAAGACAAATG). Detection of probes was achieved by using antibodies conjugated to quantum dots (Qdot) against the hapten label. Conditions were optimized to use a combination of two antibodies (1 : 200) obtained from Invitrogen&#x02013;Molecular Probes&#x02122; (Qdot 655 * sheep anti-Bio primary antibody conjugate; Qdot 525 * Goat anti-FITC whole IgG primary antibody conjugate). Image acquisition was done with a Zeiss Axioplan 2e microscope (Carl Zeiss, Inc.). All pictures in the corresponding three channels were deconvolved and optical sections merged to produce 2D pictures using Axiovision 4.0 software (Carl Zeiss, Inc.) and Image J (Rasband, W.S., ImageJ, U. S. National Institutes of Health, Bethesda, MD, USA, <a href="http://rsb.info.nih.gov/ij/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://rsb.info.nih.gov/ij/</a>, 1997&#x02013;2006.)</p></div></div><div id="__sec7" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec7title" style="text-transform: uppercase;">RESULTS</h2><div id="__sec8" class="sec sec-first"><h3 id="__sec8title">Microarray-based TMPRSS2:ERG exon fusion mapping</h3><p id="__p12" class="p p-first">To develop a multiplexing assay that is highly sensitive in clinical samples of high complexity, we adopted our Virochip system (<a href="#B25" rid="B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270269">25</a>). The key protocol, Round ABC, designed for unbiased amplification (<a href="#B29" rid="B29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270254">29</a>), is crucial for identifying various fusion variants in this application.</p><p id="__p13">Through literature review, we found that most of the TMPRSS2:ERG fusion junctions are between exons 1 or 2 of the TMPRSS2 and exons 2&#x02013;5 of the ERG (<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270271">2</a>,<a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270260">7</a>,<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270239">9</a>,<a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270304">13</a>). Such constraints perhaps are related to whether a functional ERG protein can be made from the gene fusions (<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270306">9</a>). Therefore, we initially used a pair of primers at exon 1 of the TMPRSS2 and exon 6 of the ERG for RT&#x02013;PCR. As shown in <a href="/pmc/articles/PMC2582611/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>A, PCR products were only generated when there was a gene fusion, since the two primers are located at different genes. Subsequently, the PCR products were labeled and hybridized to an exon array for mapping the exons near the fusion junction. Printed on the array are 30-mer oligonucleotide probes derived from exons 1&#x02013;3 of the TMPRSS2 and exons 1&#x02013;5 of the ERG (<a href="/pmc/articles/PMC2582611/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). Each selected sequence is represented by two complementary probes (F: forward and R: reverse complement) since sometimes PCR-labeled amplicons may bind to only one strand of the probe, based on empirical observations (<a href="#B25" rid="B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270294">25</a>). We observed that probes with reverse complementary (R) orientation worked consistently with our RT&#x02013;PCR labeling protocol.\n\n</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC2582611/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140160395274784" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2582611_gkn585f1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is gkn585f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2582611/bin/gkn585f1.jpg" /></a></div><div id="largeobj_idm140160395274784" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2582611/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC2582611/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1.</a></div><!--caption a7--><div class="caption"><p id="__p14">TMPRSS2:ERG exon mapping strategy. (<strong>A</strong>) The RT&#x02013;PCR is performed using a 3&#x02032; primer from exon 6 of the ERG and a 5&#x02032; primer from exon 1 of the TMPRSS2. Only fusion transcripts can be exponentially amplified since the two primers are at different genes. The probes on the array are derived from exons 1&#x02013;3 of the TMPRSS2 and exons 1&#x02013;5 of the ERG (<a href="/pmc/articles/PMC2582611/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). (<strong>B</strong>) The hybridization pattern of RT&#x02013;PCR labeled amplicons with total RNA derived from the VCaP cell line. The result clearly shows that the fusion junction is at exon 1 of the TMPRSS2 and exon 4 of the ERG, as illustrated in the fusion scenario in (A). A probe that spans on the junction of exon 1 and 2 of the TMPRSS2 is labeled as &#x02018;1/2&#x02019;.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1.</h3><!--caption a7--><div class="caption"><p id="__p15">Exon probes</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140160396899200" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead align="left"><tr><th rowspan="1" colspan="1">Name</th><th rowspan="1" colspan="1">Sequence</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1"><kbd>T1F</kbd></td><td rowspan="1" colspan="1"><kbd>GGGCGGGGAGCGCCGCCTGGAGCGCGGCAG</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T2F</kbd></td><td rowspan="1" colspan="1"><kbd>ACATTCCAGATACCTATCATTACTCGATGC</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T3F</kbd></td><td rowspan="1" colspan="1"><kbd>GGTCACCACCAGCTATTGGACCTTACTATG</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T1/2F</kbd></td><td rowspan="1" colspan="1"><kbd>TGGAGCGCGGCAGGTCATATTGAACATTCC</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>G1F</kbd></td><td rowspan="1" colspan="1"><kbd>AGGGACATGAGAGAAGAGGAGCGGCGCTCA</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>G2F</kbd></td><td rowspan="1" colspan="1"><kbd>AGACCCGAGGAAAGCCGTGTTGACCAAAAG</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>G3F</kbd></td><td rowspan="1" colspan="1"><kbd>GCTGGTAGATGGGCTGGCTTACTGAAGGAC</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>G4F</kbd></td><td rowspan="1" colspan="1"><kbd>TTATCAGTTGTGAGTGAGGACCAGTCGTTG</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>G5F</kbd></td><td rowspan="1" colspan="1"><kbd>CTCTCCTGATGAATGCAGTGTGGCCAAAGG</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T1R</kbd></td><td rowspan="1" colspan="1"><kbd>CTGCCGCGCTCCAGGCGGCGCTCCCCGCCC</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T2R</kbd></td><td rowspan="1" colspan="1"><kbd>GCATCGAGTAATGATAGGTATCTGGAATGT</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T3R</kbd></td><td rowspan="1" colspan="1"><kbd>CATAGTAAGGTCCAATAGCTGGTGGTGACC</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T1/2R</kbd></td><td rowspan="1" colspan="1"><kbd>GGAATGTTCAATATGACCTGCCGCGCTCCA</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>G1R</kbd></td><td rowspan="1" colspan="1"><kbd>TGAGCGCCGCTCCTCTTCTCTCATGTCCCT</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>G2R</kbd></td><td rowspan="1" colspan="1"><kbd>CTTTTGGTCAACACGGCTTTCCTCGGGTCT</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>G3R</kbd></td><td rowspan="1" colspan="1"><kbd>GTCCTTCAGTAAGCCAGCCCATCTACCAGC</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>G4R</kbd></td><td rowspan="1" colspan="1"><kbd>CAACGACTGGTCCTCACTCACAACTGATAA</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>G5R</kbd></td><td rowspan="1" colspan="1"><kbd>CCTTTGGCCACACTGCATTCATCAGGAGAG</kbd></td></tr></tbody></table></div><div id="largeobj_idm140160396899200" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2582611/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="idm140160400442064"><p id="__p16" class="p p-first-last">T, TMPRSS2; G, ERG. F, forward probe; R, reverse complement probe.</p></div></div></div><p id="__p17">A prostate cancer cell line, VCaP, (<a href="#B30" rid="B30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270302">30</a>) with a TMPRSS2 and ERG fusion (<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270252">2</a>) was used for initial feasibility testing. The total RNA was subjected to RT&#x02013;PCR with a pair of primers located at exon 6 of ERG and exon 1 of TMPRSS2 (<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270257">2</a>,<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270264">9</a>). The unpurified product was labeled and hybridized on the microarray (<a href="/pmc/articles/PMC2582611/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>B). Only spots corresponding to exon 1 of TMPRSS2 and exons 4&#x02013;5 of ERG developed strong signals. This result indicates the fusion junction is at the exon 1 of TMPRSS2 and exon 4 of ERG, which is consistent with a previous report (<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270241">2</a>).</p><p id="__p18" class="p p-last">To mimic a typical clinical situation, in which small population of cancer cells are present among normal host cells in a primary tumor, we spiked decreasing amounts of total RNA extracted from VCaP cells into an excess of HeLa RNA, which does not have the fusion transcripts. The detection limit is 32 pg of VCaP RNA in the presence of 100 ng of HeLa RNA (<a href="/pmc/articles/PMC2582611/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>). This translates into only 1&#x02013;3 cancer cells in the presence of 3000 times more normal cells. The level of sensitivity is superior to previous methods for detecting fusion transcripts (<a href="#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270289">24</a>).\n</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC2582611/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140160399804048" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2582611_gkn585f2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is gkn585f2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2582611/bin/gkn585f2.jpg" /></a></div><div id="largeobj_idm140160399804048" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2582611/figure/F2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC2582611/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2.</a></div><!--caption a7--><div class="caption"><p id="__p19">Assay sensitivity. The VCaP total RNA was serially diluted in a solution containing HeLa RNA to mimic the heterogeneous cell population in primary tumors or human body fluids. The total amount of RNA for each reaction is 100 ng. The laser power (PMT 600, 100% output) was adjusted to maximize the sensitivity of detection. Therefore, the intensity of the each expected feature (T1, G4, G5) is at the saturated level. The signal disappeared when the VCaP RNA was diluted from 1:3125 (32 pg) to 1:15625 (6.4 pg).</p></div></div></div></div><div id="__sec9" class="sec"><h3 id="__sec9title">TMPRSS2:ERG fusion junction mapping in primary prostate cancer</h3><p id="__p20" class="p p-first">To test the ability of the exon mapping array to detect and characterize TMPRSS2:ERG fusion transcripts in clinical samples, we isolated total RNA from frozen unpurified primary prostate tissues obtained during surgery. Many of these tumors had a substantial fraction of normal stromal cells. Total RNA (5&#x02013;50 ng) from prostate cancers (<em>n</em> = 20) and nonmalignant hyperplastic prostate tissues (<em>n</em> = 10) were subjected to RT&#x02013;PCR labeling and array hybridization. The results showed that 7/20 cancers but 0/10 nonmalignant samples had TMPRSS2:ERG fusion genes. To confirm the presence of the gene fusions, direct sequencing was performed for the seven samples. The sequencing data validated the exon fusion findings revealed by the array assays. Similar to other reports (<a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270249">7</a>,<a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270295">12</a>,<a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270256">13</a>), some samples clearly showed two or more bands on the agarose gel when the PCR products were subjected to electrophoresis, corresponding to two or more fusion transcripts in the same specimens.</p><p id="__p21">The multiple fusion transcripts in a single prostate cancer sample may reflect tumor heterogeneity or alternative splicing events. In order to map multiple fusion junctions in a single assay, we redesigned the exon array to include junction probes between exons 1 and 2 of the TMPRSS2 gene and exons 1&#x02013;6 of the ERG gene (<a href="/pmc/articles/PMC2582611/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). The modified probe set showed very clearly that the patient sample #15 had two fusion transcripts and also revealed the relative ratios of the two fusion transcripts through their respective signal intensities (<a href="/pmc/articles/PMC2582611/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>). In this case, the two fusion transcripts are between exon 4 of the ERG fused to either exon 1 (T1G4) or exon 2 (T2G4) of the TMPRSS2. The signal intensity of T2G4 junction probe is weaker than that of the T1G4 junction probe (<a href="/pmc/articles/PMC2582611/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>A), consistent with the intensities of the probes within the exons. These two fusion transcripts are very likely due to alternative splicing. <a href="/pmc/articles/PMC2582611/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a> summarizes the cluster analysis (<a href="#B31" rid="B31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270272">31</a>) of the seven arrays; the results are shown in <a href="/pmc/articles/PMC2582611/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>. Multiple fusion variants were found in 4/7 positive samples.\n\n\n\n</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC2582611/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140160398139440" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2582611_gkn585f3.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is gkn585f3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2582611/bin/gkn585f3.jpg" /></a></div><div id="largeobj_idm140160398139440" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2582611/figure/F3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC2582611/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3.</a></div><!--caption a7--><div class="caption"><p id="__p22">Detecting multiple fusion transcripts with junction probes. (<strong>A</strong>) The exon probes alone show the sum of the signal derived from individual transcripts. The junction probes reveal the species of the transcripts. These two sets of data together are very useful to distinguish weak but true signals from otherwise random background signals. (<strong>B</strong>) A scheme is presented to assist with data interpretation for (A), which shows coexistence of T1G4 and T2G4 transcripts.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC2582611/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140160395219136" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2582611_gkn585f4.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is gkn585f4.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2582611/bin/gkn585f4.jpg" /></a></div><div id="largeobj_idm140160395219136" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2582611/figure/F4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC2582611/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Figure 4.</a></div><!--caption a7--><div class="caption"><p id="__p23">Cluster analysis of seven prostate cancer samples having fusion transcripts. The signal intensity of each feature is divided by the intensity of a nonspecific control (herring sperm DNA) to normalize the data for cluster analysis. The result is shown in <a href="/pmc/articles/PMC2582611/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>. The samples having similar fusion transcript variants were clustered together by the program.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2.</h3><!--caption a7--><div class="caption"><p id="__p24">Junction probes</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140160396062192" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead align="left"><tr><th rowspan="1" colspan="1">Name</th><th rowspan="1" colspan="1">Sequence</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1"><kbd>T1G1F</kbd></td><td rowspan="1" colspan="1"><kbd>CCTGGAGCGCGGCAGCCCCCGAGGGACATG</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T1G2F</kbd></td><td rowspan="1" colspan="1"><kbd>CCTGGAGCGCGGCAGGTTATTCCAGGATCT</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T1G3F</kbd></td><td rowspan="1" colspan="1"><kbd>CCTGGAGCGCGGCAGCCGTCAGGTTCTGAA</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T1G4F</kbd></td><td rowspan="1" colspan="1"><kbd>CCTGGAGCGCGGCAGGAAGCCTTATCAGTT</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T1G5F</kbd></td><td rowspan="1" colspan="1"><kbd>CCTGGAGCGCGGCAGATGCCACCCCCAAAC</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T1G6F</kbd></td><td rowspan="1" colspan="1"><kbd>CCTGGAGCGCGGCAGATCCTACGCTATGGA</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T2G1F</kbd></td><td rowspan="1" colspan="1"><kbd>ATGGCTTTGAACTCACCCCCGAGGGACATG</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T2G2F</kbd></td><td rowspan="1" colspan="1"><kbd>ATGGCTTTGAACTCAGTTATTCCAGGATCT</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T2G3F</kbd></td><td rowspan="1" colspan="1"><kbd>ATGGCTTTGAACTCACCGTCAGGTTCTGAA</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T2G4F</kbd></td><td rowspan="1" colspan="1"><kbd>ATGGCTTTGAACTCAGAAGCCTTATCAGTT</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T2G5F</kbd></td><td rowspan="1" colspan="1"><kbd>ATGGCTTTGAACTCAATGCCACCCCCAAAC</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T2G6F</kbd></td><td rowspan="1" colspan="1"><kbd>ATGGCTTTGAACTCAATCCTACGCTATGGA</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T1G1R</kbd></td><td rowspan="1" colspan="1"><kbd>CATGTCCCTCGGGGGCTGCCGCGCTCCAGG</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T1G2R</kbd></td><td rowspan="1" colspan="1"><kbd>AGATCCTGGAATAACCTGCCGCGCTCCAGG</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T1G3R</kbd></td><td rowspan="1" colspan="1"><kbd>TTCAGAACCTGACGGCTGCCGCGCTCCAGG</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T1G4R</kbd></td><td rowspan="1" colspan="1"><kbd>AACTGATAAGGCTTCCTGCCGCGCTCCAGG</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T1G5R</kbd></td><td rowspan="1" colspan="1"><kbd>GTTTGGGGGTGGCATCTGCCGCGCTCCAGG</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T1G6R</kbd></td><td rowspan="1" colspan="1"><kbd>TCCATAGCGTAGGATCTGCCGCGCTCCAGG</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T2G1R</kbd></td><td rowspan="1" colspan="1"><kbd>CATGTCCCTCGGGGGTGAGTTCAAAGCCAT</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T2G2R</kbd></td><td rowspan="1" colspan="1"><kbd>AGATCCTGGAATAACTGAGTTCAAAGCCAT</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T2G3R</kbd></td><td rowspan="1" colspan="1"><kbd>TTCAGAACCTGACGGTGAGTTCAAAGCCAT</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T2G4R</kbd></td><td rowspan="1" colspan="1"><kbd>AACTGATAAGGCTTCTGAGTTCAAAGCCAT</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T2G5R</kbd></td><td rowspan="1" colspan="1"><kbd>GTTTGGGGGTGGCATTGAGTTCAAAGCCAT</kbd></td></tr><tr><td rowspan="1" colspan="1"><kbd>T2G6R</kbd></td><td rowspan="1" colspan="1"><kbd>TCCATAGCGTAGGATTGAGTTCAAAGCCAT</kbd></td></tr></tbody></table></div><div id="largeobj_idm140160396062192" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2582611/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="idm140160333131936"><p id="__p25" class="p p-first-last">T, TMPRSS2; G, ERG. F, forward probe; R, reverse complement probe.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T3"><h3>Table 3.</h3><!--caption a7--><div class="caption"><p id="__p26">The percentage of cancer cells in the tumors, the Gleason tumor grades and the detected variants of TMPRSS2:ERG fusion transcripts</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140160399819632" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead align="left"><tr><th rowspan="1" colspan="1">Sample no.</th><th rowspan="1" colspan="1">Cancer (%)</th><th rowspan="1" colspan="1">Gleason grade</th><th rowspan="1" colspan="1">Fusion transcripts</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">30</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">T1-G4; T2-G4</td></tr><tr><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">50</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">T1-G4</td></tr><tr><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">90</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">T1-G2</td></tr><tr><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">70</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">13</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">T1-G4</td></tr><tr><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">70</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">T1-G4; T2-G4</td></tr><tr><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">17</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">T1-G4; T2-G4</td></tr><tr><td rowspan="1" colspan="1">18</td><td rowspan="1" colspan="1">50</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">T1-G2; T1-G3; T1-G4</td></tr><tr><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1"></td></tr></tbody></table></div><div id="largeobj_idm140160399819632" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2582611/table/T3/?report=objectonly">Open in a separate window</a></div></div><p id="__p27" class="p p-last"><a href="/pmc/articles/PMC2582611/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a> also lists the percentages of cancer cells in the tumors, the Gleason tumor grades and the detected variants of TMPRSS2:ERG fusion transcripts. In this small sample set, there is no clear association between tumor grade and the presence of fusion transcripts. A relatively larger study also showed that the presence of fusion transcript was associated with tumor stage but not tumor grade (<a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270297">12</a>). Consistent with the VCaP titration study (<a href="/pmc/articles/PMC2582611/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>), the clinical assay can detect the fusion transcript when only 1% tumor cells is present in the prostate tissue (sample 10).</p></div><div id="__sec10" class="sec sec-last"><h3 id="__sec10title">FISH analysis</h3><p id="__p28" class="p p-first-last">We used FISH analysis to independently confirm our array approach. Our FISH procedure (<a href="#B28" rid="B28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270237">28</a>) employed 50-mer probes that were labeled with small haptens for target hybridization in conjunction with individual hapten-specific, quantum dot conjugated antibodies for signal detection. The resolution of this method is &#x0223c;50 kb. We designed two probes for the FISH assays, one at the promoter region of TMPRSS2 (green in <a href="/pmc/articles/PMC2582611/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5</span></a>) and the other at exon 2 of ERG (red in <a href="/pmc/articles/PMC2582611/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5</span></a>). We observed heterogeneity of the FISH patterns in some primary prostate cancer samples (<a href="/pmc/articles/PMC2582611/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Figure 5</span></a>). It is more difficult to find interstitial deletions between TMPRSS2 and ERG in tumor samples containing low percentages of cancer cells by FISH. Therefore, we used samples that contained &#x0003e;80% cancer cells without detectable fusion genes to confirm the results of the arrays. The FISH experiments revealed no genomic deletions at this location for all the selected samples (#5, #7, #9, #19 and #20) that were similarly nondeleted by array hybridization.\n</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F5" co-legend-rid="lgnd_F5"><a href="/pmc/articles/PMC2582611/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140160400253872" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2582611_gkn585f5.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is gkn585f5.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2582611/bin/gkn585f5.jpg" /></a></div><div id="largeobj_idm140160400253872" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2582611/figure/F5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F5"><div><a class="figpopup" href="/pmc/articles/PMC2582611/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5">Figure 5.</a></div><!--caption a7--><div class="caption"><p id="__p29">Heterogeneity of FISH patterns of interstitial deletion between TMPRSS2 and ERG in a primary prostate tumor. An unpaired green dot (TMPRSS2 probe, indicated by arrows) suggests an interstitial deletion. Nonrandom variation of FISH patterns is shown by the fact that most of the green and red signals (two different but nearby probes) are paired in each panel. This variation is expected on a heterogeneous aneuploid cancer cell population, which often makes it difficult to distinguish meaningful events from random background aberrations.</p></div></div></div></div></div><div id="__sec11" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec11title" style="text-transform: uppercase;">DISCUSSION</h2><p id="__p30" class="p p-first">We have established a simple assay that can concurrently profile variants of TMPRSS2:ERG fusion transcripts by combining a single RT&#x02013;PCR with an exon array. The modified &#x02018;Round ABC&#x02019; protocol, which was originally designed for genomic amplification (<a href="#B29" rid="B29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270276">29</a>) and has been widely adopted for chromatin immunoprecipitation (ChIP) and whole-genome DNA microarrays (ChIP-chip) (<a href="#B32" rid="B32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270292">32</a>,<a href="#B33" rid="B33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270310">33</a>) and Virochip (<a href="#B25" rid="B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270268">25</a>,<a href="#B34" rid="B34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270245">34</a>) experiments, is a simple and relatively unbiased amplification procedure to semi-quantitatively measure the fusion variants in a complex sample. Previously, the same simple procedure was used to obtain 83% (25 kb/30 kb) of the SARS coronavirus genome with total nucleic acids isolated from a viral culture (<a href="#B25" rid="B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270285">25</a>).</p><p id="__p31">The inclusion within the array of probes derived from individual exons and potential fusion junctions simplifies the breakpoint mapping and increases the confidence of data interpretation (<a href="/pmc/articles/PMC2582611/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figures 3</span></a> and <a href="#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270273">4</a>). In contrast to some reports that used multiple primers targeted to every potential fusion junction in hematological malignancies (<a href="#B35" rid="B35 B36 B37 B38" class=" bibr popnode">35&#x02013;38</a>), we used a single set of primers for target amplification (<a href="/pmc/articles/PMC2582611/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>). The fusion junctions were subsequently decoded by array. This design significantly reduces the problems associated with primer dimers in the multiplex PCR reaction, and creates more room for future assays to include additional fusion genes. Furthermore, most searches for fusion genes have focused on blood cancers, because the cells can be purified before analysis. The application of the previous methodologies is less useful for highly complex solid tumors that are inevitably admixed with normal cells. For example, a previously reported MLLFusionChip could not be applied to samples with cancer cells of &#x0003c;5&#x02013;10% in 1 &#x003bc;g of total RNA (<a href="#B39" rid="B39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270267">39</a>).</p><p id="__p32">The current assay should facilitate a thorough compilation of the gene fusion variants in primary prostate specimens, which may be useful for stratifying the aggressiveness of prostate cancer (<a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270238">13</a>). In this regard, fusion variants of EWS with another member of the ETS family, FLI1, have been shown to be an independent predictor of disease progression in Ewing\'s sarcoma (<a href="#B40" rid="B40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270315">40</a>,<a href="#B41" rid="B41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270259">41</a>). It will be of interest to compare in transfected cells the biological activities of the different TMPRSS2:ERG variants from patients with contrasting clinical outcomes (<a href="#B41" rid="B41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270296">41</a>).</p><p id="__p33">While some studies have suggested that the presence of TMPRSS2:ERG fusions is associated with more aggressive disease or higher Gleason tumor grade, other investigators did not reach the same conclusion (<a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270287">12</a>,<a href="#B14" rid="B14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270298">14</a>,<a href="#B17" rid="B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270240">17</a>,<a href="#B20" rid="B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270312">20</a>,<a href="#B23" rid="B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270270">23</a>,<a href="#B42" rid="B42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270279">42</a>). We also did not find such an association in a small series of samples. However, all of these results are defective due to small sample size. The technology described here should make possible a larger scale investigation to find whether there is a correlation between the aggressiveness of the disease and the presence of specific fusion genes.</p><p id="__p34">It is crucial to have true cancer-specific biomarkers for early cancer detection as well as for minimal residual disease monitoring, which has been extensively demonstrated in hematologic maligancies (<a href="#B43" rid="B43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270281">43</a>). Such biomarkers could help to avoid under- or over-treatment. Thus, there is past interest (<a href="#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270266">24</a>,<a href="#B44" rid="B44" class=" bibr popnode">44</a>) in applying TMPRSS2:ERG fusion assays for such application since PSA and many other markers in development are not truly prostate cancer-specific (<a href="#B45" rid="B45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270243">45</a>). A recent study reported a TMPRSS2:ERG assay with a sensitivity of detecting 1600 VCaP cells (<a href="#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270288">24</a>). However, this level of sensitivity might not be sufficient for broad clinical application, especially with small biopsy specimens or urine samples. We were able to achieve an assay sensitivity of &#x0003c;32 pg of total RNA derived from VCaP cells, an equivalent to 1&#x02013;3 cells (<a href="/pmc/articles/PMC2582611/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>). Because our assay is simple and amenable to automation, it is readily adaptable to clinical studies. While it has been challenging to adapt microarray-based technology to the clinic, some tests (e.g. AmpliChip CYP450 and MammaPrint) have been approved by FDA (<a href="#B46" rid="B46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270246">46</a>).</p><p id="__p35">The same strategy can be applied to detect other less prevalent fusion transcripts (TMPRSS2:ETV1 and TMPRSS2:ETV4) in prostate cancer (<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270250">2</a>,<a href="#B5" rid="B5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270284">5</a>,<a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270286">6</a>). In addition, the exon array approach can also be applied to other fusion genes, such as BCR-ABL in CML and clonal Ig/TCR rearrangements in lymphocytic malignancies. While this methodology development was motivated by the clinical need, it is generally applicable to other research requirements that are analogous to the situation for detecting fusion genes in the single cell level when a large excess of normal cells are present. For example, a developmental biologist may use a similar approach to screen mutants that have a desirable gene fusion when direct gene targeting is not feasible.</p><p id="__p36" class="p p-last">There are some shortcomings of using RNA transcripts as prostate cancer biomarkers, despite our ability to achieve very sensitive detection of TMPRSS2:ERG fusion variants. First, RNA is unstable and difficult to process in routine clinical assays. Second, commonly used drugs that inhibit androgen growth pathways, including GnRH agonists and testosterone antagonists, may diminish the production of the TMPRSS2:ERG mRNA fusion transcript, thereby producing false-negative results in patients on hormonal therapy with evolving androgen-independent tumors. Indeed, it has been reported that TMPRSS2:ERG mRNA fusion transcripts are not expressed in androgen-independent tumors in spite of the presence of interstitial deletions in between TMPRSS2 and ERG at chromosome 21q22 (<a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270242">10</a>). While FISH is useful for identifying genomic rearrangements, it has relatively lower resolution and is difficult to use in highly heterogeneous samples with small percentages of tumor cells. We have recently developed a technology, designated Primer Approximation Multiplex PCR (PAMP) for identifying breakpoints in genomic DNA without the need to purify cancer cells from normal tissues (<a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_294270309">26</a>). We are optimizing this assay for detecting the breakpoints between TMPRSS2 and ERG loci for primary prostate tumors to overcome any potential problems associated with RNA based biomarkers. In addition, the DNA-based assay will provide information about whether multiple fusion transcripts in a sample are derived from alternative splicing or tumor heterogeneity. The best approach may ultimately be to combine DNA and RNA based assays in a common format.</p></div><div id="__sec12" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec12title" style="text-transform: uppercase;">FUNDING</h2><p id="__p37" class="p p-first">National Institutes of Health (<span>CA119335</span>; to UCSD NanoTumor Center of Excellence for Cancer Nanotechnology, <span>CA133634</span>; to Y. T. Liu, <span>NS034934</span> to M.G. Rosenfeld); NCI Cancer Center (2 P30 CA023100-23 to DNA Sequencing Shared Resource, UCSD Cancer Center) partially. Funding for open access charge: CA133634.</p><p id="__p38" class="p p-last"><em>Conflict of interest statement</em>. None declared.</p></div><div id="idm140160400397104" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140160400397104title" style="text-transform: uppercase;">REFERENCES</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="B1">1. <span class="element-citation">Mitelman F, Johansson B, Mertens F. The impact of translocations and gene fusions on cancer causation. <span><span class="ref-journal">Nat. Rev. Cancer. </span>2007;<span class="ref-vol">7</span>:233\xe2\x80\x93245.</span> [<a href="/pubmed/17361217" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Rev.+Cancer&amp;title=The+impact+of+translocations+and+gene+fusions+on+cancer+causation&amp;author=F+Mitelman&amp;author=B+Johansson&amp;author=F+Mertens&amp;volume=7&amp;publication_year=2007&amp;pages=233-245&amp;pmid=17361217&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B2">2. <span class="element-citation">Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, et al.  Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. <span><span class="ref-journal">Science. </span>2005;<span class="ref-vol">310</span>:644\xe2\x80\x93648.</span> [<a href="/pubmed/16254181" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Recurrent+fusion+of+TMPRSS2+and+ETS+transcription+factor+genes+in+prostate+cancer&amp;author=SA+Tomlins&amp;author=DR+Rhodes&amp;author=S+Perner&amp;author=SM+Dhanasekaran&amp;author=R+Mehra&amp;volume=310&amp;publication_year=2005&amp;pages=644-648&amp;pmid=16254181&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B3">3. <span class="element-citation">Melo JV, Barnes DJ. Chronic myeloid leukaemia as a model of disease evolution in human cancer. <span><span class="ref-journal">Nat. Rev. Cancer. </span>2007;<span class="ref-vol">7</span>:441\xe2\x80\x93453.</span> [<a href="/pubmed/17522713" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Rev.+Cancer&amp;title=Chronic+myeloid+leukaemia+as+a+model+of+disease+evolution+in+human+cancer&amp;author=JV+Melo&amp;author=DJ+Barnes&amp;volume=7&amp;publication_year=2007&amp;pages=441-453&amp;pmid=17522713&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B4">4. <span class="element-citation">Hughes T, Deininger M, Hochhaus A, Branford S, Radich J, Kaeda J, Baccarani M, Cortes J, Cross NC, Druker BJ, et al.  Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. <span><span class="ref-journal">Blood. </span>2006;<span class="ref-vol">108</span>:28\xe2\x80\x9337.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1895821/">PMC free article</a>]</span> [<a href="/pubmed/16522812" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Monitoring+CML+patients+responding+to+treatment+with+tyrosine+kinase+inhibitors:+review+and+recommendations+for+harmonizing+current+methodology+for+detecting+BCR-ABL+transcripts+and+kinase+domain+mutations+and+for+expressing+results&amp;author=T+Hughes&amp;author=M+Deininger&amp;author=A+Hochhaus&amp;author=S+Branford&amp;author=J+Radich&amp;volume=108&amp;publication_year=2006&amp;pages=28-37&amp;pmid=16522812&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B5">5. <span class="element-citation">Tomlins SA, Mehra R, Rhodes DR, Smith LR, Roulston D, Helgeson BE, Cao X, Wei JT, Rubin MA, Shah RB, et al.  TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. <span><span class="ref-journal">Cancer Res. </span>2006;<span class="ref-vol">66</span>:3396\xe2\x80\x933400.</span> [<a href="/pubmed/16585160" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res.&amp;title=TMPRSS2:ETV4+gene+fusions+define+a+third+molecular+subtype+of+prostate+cancer&amp;author=SA+Tomlins&amp;author=R+Mehra&amp;author=DR+Rhodes&amp;author=LR+Smith&amp;author=D+Roulston&amp;volume=66&amp;publication_year=2006&amp;pages=3396-3400&amp;pmid=16585160&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B6">6. <span class="element-citation">Lapointe J, Kim YH, Miller MA, Li C, Kaygusuz G, van de Rijn M, Huntsman DG, Brooks JD, Pollack JR. A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis. <span><span class="ref-journal">Mod. Pathol. </span>2007;<span class="ref-vol">20</span>:467\xe2\x80\x93473.</span> [<a href="/pubmed/17334351" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mod.+Pathol.&amp;title=A+variant+TMPRSS2+isoform+and+ERG+fusion+product+in+prostate+cancer+with+implications+for+molecular+diagnosis&amp;author=J+Lapointe&amp;author=YH+Kim&amp;author=MA+Miller&amp;author=C+Li&amp;author=G+Kaygusuz&amp;volume=20&amp;publication_year=2007&amp;pages=467-473&amp;pmid=17334351&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B7">7. <span class="element-citation">Soller MJ, Isaksson M, Elfving P, Soller W, Lundgren R, Panagopoulos I. Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer. <span><span class="ref-journal">Genes Chromosomes Cancer. </span>2006;<span class="ref-vol">45</span>:717\xe2\x80\x93719.</span> [<a href="/pubmed/16575875" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genes+Chromosomes+Cancer&amp;title=Confirmation+of+the+high+frequency+of+the+TMPRSS2/ERG+fusion+gene+in+prostate+cancer&amp;author=MJ+Soller&amp;author=M+Isaksson&amp;author=P+Elfving&amp;author=W+Soller&amp;author=R+Lundgren&amp;volume=45&amp;publication_year=2006&amp;pages=717-719&amp;pmid=16575875&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B8">8. <span class="element-citation">Cerveira N, Ribeiro FR, Peixoto A, Costa V, Henrique R, Jeronimo C, Teixeira MR. TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions. <span><span class="ref-journal">Neoplasia. </span>2006;<span class="ref-vol">8</span>:826\xe2\x80\x93832.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1715930/">PMC free article</a>]</span> [<a href="/pubmed/17032499" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neoplasia&amp;title=TMPRSS2-ERG+gene+fusion+causing+ERG+overexpression+precedes+chromosome+copy+number+changes+in+prostate+carcinomas+and+paired+HGPIN+lesions&amp;author=N+Cerveira&amp;author=FR+Ribeiro&amp;author=A+Peixoto&amp;author=V+Costa&amp;author=R+Henrique&amp;volume=8&amp;publication_year=2006&amp;pages=826-832&amp;pmid=17032499&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B9">9. <span class="element-citation">Clark J, Merson S, Jhavar S, Flohr P, Edwards S, Foster CS, Eeles R, Martin FL, Phillips DH, Crundwell M, et al.  Diversity of TMPRSS2-ERG fusion transcripts in the human prostate. <span><span class="ref-journal">Oncogene. </span>2007;<span class="ref-vol">26</span>:2667\xe2\x80\x932673.</span> [<a href="/pubmed/17043636" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Diversity+of+TMPRSS2-ERG+fusion+transcripts+in+the+human+prostate&amp;author=J+Clark&amp;author=S+Merson&amp;author=S+Jhavar&amp;author=P+Flohr&amp;author=S+Edwards&amp;volume=26&amp;publication_year=2007&amp;pages=2667-2673&amp;pmid=17043636&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B10">10. <span class="element-citation">Hermans KG, van Marion R, van Dekken H, Jenster G, van Weerden WM, Trapman J. TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer. <span><span class="ref-journal">Cancer Res. </span>2006;<span class="ref-vol">66</span>:10658\xe2\x80\x9310663.</span> [<a href="/pubmed/17108102" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res.&amp;title=TMPRSS2:ERG+fusion+by+translocation+or+interstitial+deletion+is+highly+relevant+in+androgen-dependent+prostate+cancer,+but+is+bypassed+in+late-stage+androgen+receptor-negative+prostate+cancer&amp;author=KG+Hermans&amp;author=R+van+Marion&amp;author=H+van+Dekken&amp;author=G+Jenster&amp;author=WM+van+Weerden&amp;volume=66&amp;publication_year=2006&amp;pages=10658-10663&amp;pmid=17108102&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B11">11. <span class="element-citation">Iljin K, Wolf M, Edgren H, Gupta S, Kilpinen S, Skotheim RI, Peltola M, Smit F, Verhaegh G, Schalken J, et al.  TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming. <span><span class="ref-journal">Cancer Res. </span>2006;<span class="ref-vol">66</span>:10242\xe2\x80\x9310246.</span> [<a href="/pubmed/17079440" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res.&amp;title=TMPRSS2+fusions+with+oncogenic+ETS+factors+in+prostate+cancer+involve+unbalanced+genomic+rearrangements+and+are+associated+with+HDAC1+and+epigenetic+reprogramming&amp;author=K+Iljin&amp;author=M+Wolf&amp;author=H+Edgren&amp;author=S+Gupta&amp;author=S+Kilpinen&amp;volume=66&amp;publication_year=2006&amp;pages=10242-10246&amp;pmid=17079440&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B12">12. <span class="element-citation">Perner S, Demichelis F, Beroukhim R, Schmidt FH, Mosquera JM, Setlur S, Tchinda J, Tomlins SA, Hofer MD, Pienta KG, et al.  TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. <span><span class="ref-journal">Cancer Res. </span>2006;<span class="ref-vol">66</span>:8337\xe2\x80\x938341.</span> [<a href="/pubmed/16951139" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res.&amp;title=TMPRSS2:ERG+fusion-associated+deletions+provide+insight+into+the+heterogeneity+of+prostate+cancer&amp;author=S+Perner&amp;author=F+Demichelis&amp;author=R+Beroukhim&amp;author=FH+Schmidt&amp;author=JM+Mosquera&amp;volume=66&amp;publication_year=2006&amp;pages=8337-8341&amp;pmid=16951139&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B13">13. <span class="element-citation">Wang J, Cai Y, Ren C, Ittmann M. Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer. <span><span class="ref-journal">Cancer Res. </span>2006;<span class="ref-vol">66</span>:8347\xe2\x80\x938351.</span> [<a href="/pubmed/16951141" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res.&amp;title=Expression+of+variant+TMPRSS2/ERG+fusion+messenger+RNAs+is+associated+with+aggressive+prostate+cancer&amp;author=J+Wang&amp;author=Y+Cai&amp;author=C+Ren&amp;author=M+Ittmann&amp;volume=66&amp;publication_year=2006&amp;pages=8347-8351&amp;pmid=16951141&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B14">14. <span class="element-citation">Demichelis F, Fall K, Perner S, Andren O, Schmidt F, Setlur SR, Hoshida Y, Mosquera JM, Pawitan Y, Lee C, et al.  TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. <span><span class="ref-journal">Oncogene. </span>2007;<span class="ref-vol">26</span>:4596\xe2\x80\x934599.</span> [<a href="/pubmed/17237811" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=TMPRSS2:ERG+gene+fusion+associated+with+lethal+prostate+cancer+in+a+watchful+waiting+cohort&amp;author=F+Demichelis&amp;author=K+Fall&amp;author=S+Perner&amp;author=O+Andren&amp;author=F+Schmidt&amp;volume=26&amp;publication_year=2007&amp;pages=4596-4599&amp;pmid=17237811&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B15">15. <span class="element-citation">Mehra R, Tomlins SA, Shen R, Nadeem O, Wang L, Wei JT, Pienta KJ, Ghosh D, Rubin MA, Chinnaiyan AM, et al.  Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer. <span><span class="ref-journal">Mod. Pathol. </span>2007;<span class="ref-vol">20</span>:538\xe2\x80\x93544.</span> [<a href="/pubmed/17334343" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mod.+Pathol.&amp;title=Comprehensive+assessment+of+TMPRSS2+and+ETS+family+gene+aberrations+in+clinically+localized+prostate+cancer&amp;author=R+Mehra&amp;author=SA+Tomlins&amp;author=R+Shen&amp;author=O+Nadeem&amp;author=L+Wang&amp;volume=20&amp;publication_year=2007&amp;pages=538-544&amp;pmid=17334343&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B16">16. <span class="element-citation">Nam RK, Sugar L, Wang Z, Yang W, Kitching R, Klotz LH, Venkateswaran V, Narod SA, Seth A. Expression of TMPRSS2 ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression. <span><span class="ref-journal">Cancer Biol. Ther. </span>2007;<span class="ref-vol">6</span>:40\xe2\x80\x9345.</span> [<a href="/pubmed/17172822" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Biol.+Ther.&amp;title=Expression+of+TMPRSS2+ERG+gene+fusion+in+prostate+cancer+cells+is+an+important+prognostic+factor+for+cancer+progression&amp;author=RK+Nam&amp;author=L+Sugar&amp;author=Z+Wang&amp;author=W+Yang&amp;author=R+Kitching&amp;volume=6&amp;publication_year=2007&amp;pages=40-45&amp;pmid=17172822&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B17">17. <span class="element-citation">Rajput AB, Miller MA, De Luca A, Boyd N, Leung S, Hurtado-Coll A, Fazli L, Jones EC, Palmer JB, Gleave ME, et al.  Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers. <span><span class="ref-journal">J. Clin. Pathol. </span>2007;<span class="ref-vol">60</span>:1238\xe2\x80\x931243.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2095486/">PMC free article</a>]</span> [<a href="/pubmed/17259299" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Clin.+Pathol.&amp;title=Frequency+of+the+TMPRSS2:ERG+gene+fusion+is+increased+in+moderate+to+poorly+differentiated+prostate+cancers&amp;author=AB+Rajput&amp;author=MA+Miller&amp;author=A+De+Luca&amp;author=N+Boyd&amp;author=S+Leung&amp;volume=60&amp;publication_year=2007&amp;pages=1238-1243&amp;pmid=17259299&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B18">18. <span class="element-citation">Tomlins SA, Laxman B, Dhanasekaran SM, Helgeson BE, Cao X, Morris DS, Menon A, Jing X, Cao Q, Han B, et al.  Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. <span><span class="ref-journal">Nature. </span>2007;<span class="ref-vol">448</span>:595\xe2\x80\x93599.</span> [<a href="/pubmed/17671502" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Distinct+classes+of+chromosomal+rearrangements+create+oncogenic+ETS+gene+fusions+in+prostate+cancer&amp;author=SA+Tomlins&amp;author=B+Laxman&amp;author=SM+Dhanasekaran&amp;author=BE+Helgeson&amp;author=X+Cao&amp;volume=448&amp;publication_year=2007&amp;pages=595-599&amp;pmid=17671502&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B19">19. <span class="element-citation">Tomlins SA, Laxman B, Varambally S, Cao X, Yu J, Helgeson BE, Cao Q, Prensner JR, Rubin MA, Shah RB, et al.  Role of the TMPRSS2-ERG gene fusion in prostate cancer. <span><span class="ref-journal">Neoplasia. </span>2008;<span class="ref-vol">10</span>:177\xe2\x80\x93188.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2244693/">PMC free article</a>]</span> [<a href="/pubmed/18283340" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neoplasia&amp;title=Role+of+the+TMPRSS2-ERG+gene+fusion+in+prostate+cancer&amp;author=SA+Tomlins&amp;author=B+Laxman&amp;author=S+Varambally&amp;author=X+Cao&amp;author=J+Yu&amp;volume=10&amp;publication_year=2008&amp;pages=177-188&amp;pmid=18283340&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B20">20. <span class="element-citation">Kumar-Sinha C, Tomlins SA, Chinnaiyan AM. Recurrent gene fusions in prostate cancer. <span><span class="ref-journal">Nat. Rev. Cancer. </span>2008;<span class="ref-vol">8</span>:497\xe2\x80\x93511.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2711688/">PMC free article</a>]</span> [<a href="/pubmed/18563191" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Rev.+Cancer&amp;title=Recurrent+gene+fusions+in+prostate+cancer&amp;author=C+Kumar-Sinha&amp;author=SA+Tomlins&amp;author=AM+Chinnaiyan&amp;volume=8&amp;publication_year=2008&amp;pages=497-511&amp;pmid=18563191&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B21">21. <span class="element-citation">Rubin MA. Targeted therapy of cancer: new roles for pathologists&#x02013;prostate cancer. <span><span class="ref-journal">Mod. Pathol. </span>2008;<span class="ref-vol">21</span>(Suppl. 2):S44\xe2\x80\x93S55.</span> [<a href="/pubmed/18437173" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mod.+Pathol.&amp;title=Targeted+therapy+of+cancer:+new+roles+for+pathologists&#x02013;prostate+cancer&amp;author=MA+Rubin&amp;volume=21&amp;issue=Suppl.+2&amp;publication_year=2008&amp;pages=S44-S55&amp;pmid=18437173&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B22">22. <span class="element-citation">Stuart RO, Wachsman W, Berry CC, Wang-Rodriguez J, Wasserman L, Klacansky I, Masys D, Arden K, Goodison S, McClelland M, et al.  In silico dissection of cell-type-associated patterns of gene expression in prostate cancer. <span><span class="ref-journal">Proc. Natl Acad. Sci. USA. </span>2004;<span class="ref-vol">101</span>:615\xe2\x80\x93620.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC327196/">PMC free article</a>]</span> [<a href="/pubmed/14722351" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl+Acad.+Sci.+USA&amp;title=In+silico+dissection+of+cell-type-associated+patterns+of+gene+expression+in+prostate+cancer&amp;author=RO+Stuart&amp;author=W+Wachsman&amp;author=CC+Berry&amp;author=J+Wang-Rodriguez&amp;author=L+Wasserman&amp;volume=101&amp;publication_year=2004&amp;pages=615-620&amp;pmid=14722351&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B23">23. <span class="element-citation">Yoshimoto M, Joshua AM, Chilton-Macneill S, Bayani J, Selvarajah S, Evans AJ, Zielenska M, Squire JA. Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement. <span><span class="ref-journal">Neoplasia. </span>2006;<span class="ref-vol">8</span>:465\xe2\x80\x93469.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1601467/">PMC free article</a>]</span> [<a href="/pubmed/16820092" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neoplasia&amp;title=Three-color+FISH+analysis+of+TMPRSS2/ERG+fusions+in+prostate+cancer+indicates+that+genomic+microdeletion+of+chromosome+21+is+associated+with+rearrangement&amp;author=M+Yoshimoto&amp;author=AM+Joshua&amp;author=S+Chilton-Macneill&amp;author=J+Bayani&amp;author=S+Selvarajah&amp;volume=8&amp;publication_year=2006&amp;pages=465-469&amp;pmid=16820092&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B24">24. <span class="element-citation">Laxman B, Tomlins SA, Mehra R, Morris DS, Wang L, Helgeson BE, Shah RB, Rubin MA, Wei JT, Chinnaiyan AM. Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer. <span><span class="ref-journal">Neoplasia. </span>2006;<span class="ref-vol">8</span>:885\xe2\x80\x93888.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1715928/">PMC free article</a>]</span> [<a href="/pubmed/17059688" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neoplasia&amp;title=Noninvasive+detection+of+TMPRSS2:ERG+fusion+transcripts+in+the+urine+of+men+with+prostate+cancer&amp;author=B+Laxman&amp;author=SA+Tomlins&amp;author=R+Mehra&amp;author=DS+Morris&amp;author=L+Wang&amp;volume=8&amp;publication_year=2006&amp;pages=885-888&amp;pmid=17059688&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B25">25. <span class="element-citation">Wang D, Urisman A, Liu YT, Springer M, Ksiazek TG, Erdman DD, Mardis ER, Hickenbotham M, Magrini V, Eldred J, et al.  Viral discovery and sequence recovery using DNA microarrays. <span><span class="ref-journal">PLoS Biol. </span>2003;<span class="ref-vol">1</span>:E2.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC261870/">PMC free article</a>]</span> [<a href="/pubmed/14624234" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Biol.&amp;title=Viral+discovery+and+sequence+recovery+using+DNA+microarrays&amp;author=D+Wang&amp;author=A+Urisman&amp;author=YT+Liu&amp;author=M+Springer&amp;author=TG+Ksiazek&amp;volume=1&amp;publication_year=2003&amp;pages=E2&amp;pmid=14624234&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B26">26. <span class="element-citation">Liu YT, Carson DA. A novel approach for determining cancer genomic breakpoints in the presence of normal DNA. <span><span class="ref-journal">PLoS ONE. </span>2007;<span class="ref-vol">2</span>:e380.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1847701/">PMC free article</a>]</span> [<a href="/pubmed/17440616" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+ONE&amp;title=A+novel+approach+for+determining+cancer+genomic+breakpoints+in+the+presence+of+normal+DNA&amp;author=YT+Liu&amp;author=DA+Carson&amp;volume=2&amp;publication_year=2007&amp;pages=e380&amp;pmid=17440616&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B27">27. <span class="element-citation">Eisen MB, Brown PO. DNA arrays for analysis of gene expression. <span><span class="ref-journal">Methods Enzymol. </span>1999;<span class="ref-vol">303</span>:179\xe2\x80\x93205.</span> [<a href="/pubmed/10349646" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Methods+Enzymol.&amp;title=DNA+arrays+for+analysis+of+gene+expression&amp;author=MB+Eisen&amp;author=PO+Brown&amp;volume=303&amp;publication_year=1999&amp;pages=179-205&amp;pmid=10349646&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B28">28. <span class="element-citation">Lunyak VV, Prefontaine GG, Nunez E, Cramer T, Ju BG, Ohgi KA, Hutt K, Roy R, Garcia-Diaz A, Zhu X, et al.  Developmentally regulated activation of a SINE B2 repeat as a domain boundary in organogenesis. <span><span class="ref-journal">Science. </span>2007;<span class="ref-vol">317</span>:248\xe2\x80\x93251.</span> [<a href="/pubmed/17626886" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science.&amp;title=Developmentally+regulated+activation+of+a+SINE+B2+repeat+as+a+domain+boundary+in+organogenesis&amp;author=VV+Lunyak&amp;author=GG+Prefontaine&amp;author=E+Nunez&amp;author=T+Cramer&amp;author=BG+Ju&amp;volume=317&amp;publication_year=2007&amp;pages=248-251&amp;pmid=17626886&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B29">29. <span class="element-citation">Bohlander SK, Espinosa R., III, Le Beau MM, Rowley JD, Diaz MO. A method for the rapid sequence-independent amplification of microdissected chromosomal material. <span><span class="ref-journal">Genomics. </span>1992;<span class="ref-vol">13</span>:1322\xe2\x80\x931324.</span> [<a href="/pubmed/1505965" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genomics&amp;title=A+method+for+the+rapid+sequence-independent+amplification+of+microdissected+chromosomal+material&amp;author=SK+Bohlander&amp;author=R.+Espinosa&amp;author=MM+Le+Beau&amp;author=JD+Rowley&amp;author=MO+Diaz&amp;volume=13&amp;publication_year=1992&amp;pages=1322-1324&amp;pmid=1505965&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B30">30. <span class="element-citation">Korenchuk S, Lehr JE, Mclean L, Lee YG, Whitney S, Vessella R, Lin DL, Pienta KJ. VCaP, a cell-based model system of human prostate cancer. <span><span class="ref-journal">In Vivo. </span>2001;<span class="ref-vol">15</span>:163\xe2\x80\x93168.</span> [<a href="/pubmed/11317522" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=In+Vivo&amp;title=VCaP,+a+cell-based+model+system+of+human+prostate+cancer&amp;author=S+Korenchuk&amp;author=JE+Lehr&amp;author=L+Mclean&amp;author=YG+Lee&amp;author=S+Whitney&amp;volume=15&amp;publication_year=2001&amp;pages=163-168&amp;pmid=11317522&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B31">31. <span class="element-citation">Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. <span><span class="ref-journal">Proc. Natl Acad. Sci. USA. </span>1998;<span class="ref-vol">95</span>:14863\xe2\x80\x9314868.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC24541/">PMC free article</a>]</span> [<a href="/pubmed/9843981" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl+Acad.+Sci.+USA&amp;title=Cluster+analysis+and+display+of+genome-wide+expression+patterns&amp;author=MB+Eisen&amp;author=PT+Spellman&amp;author=PO+Brown&amp;author=D+Botstein&amp;volume=95&amp;publication_year=1998&amp;pages=14863-14868&amp;pmid=9843981&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B32">32. <span class="element-citation">Lieb JD, Liu X, Botstein D, Brown PO. Promoter-specific binding of Rap1 revealed by genome-wide maps of protein-DNA association. <span><span class="ref-journal">Nat. Genet. </span>2001;<span class="ref-vol">28</span>:327\xe2\x80\x93334.</span> [<a href="/pubmed/11455386" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Genet.&amp;title=Promoter-specific+binding+of+Rap1+revealed+by+genome-wide+maps+of+protein-DNA+association&amp;author=JD+Lieb&amp;author=X+Liu&amp;author=D+Botstein&amp;author=PO+Brown&amp;volume=28&amp;publication_year=2001&amp;pages=327-334&amp;pmid=11455386&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B33">33. <span class="element-citation">Buck MJ, Lieb JD. ChIP-chip: considerations for the design, analysis, and application of genome-wide chromatin immunoprecipitation experiments. <span><span class="ref-journal">Genomics. </span>2004;<span class="ref-vol">83</span>:349\xe2\x80\x93360.</span> [<a href="/pubmed/14986705" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genomics&amp;title=ChIP-chip:+considerations+for+the+design,+analysis,+and+application+of+genome-wide+chromatin+immunoprecipitation+experiments&amp;author=MJ+Buck&amp;author=JD+Lieb&amp;volume=83&amp;publication_year=2004&amp;pages=349-360&amp;pmid=14986705&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B34">34. <span class="element-citation">Palacios G, Quan PL, Jabado OJ, Conlan S, Hirschberg DL, Liu Y, Zhai J, Renwick N, Hui J, Hegyi H, et al.  Panmicrobial oligonucleotide array for diagnosis of infectious diseases. <span><span class="ref-journal">Emerg. Infect. Dis. </span>2007;<span class="ref-vol">13</span>:73\xe2\x80\x9381.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2725825/">PMC free article</a>]</span> [<a href="/pubmed/17370518" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Emerg.+Infect.+Dis.&amp;title=Panmicrobial+oligonucleotide+array+for+diagnosis+of+infectious+diseases&amp;author=G+Palacios&amp;author=PL+Quan&amp;author=OJ+Jabado&amp;author=S+Conlan&amp;author=DL+Hirschberg&amp;volume=13&amp;publication_year=2007&amp;pages=73-81&amp;pmid=17370518&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B35">35. <span class="element-citation">Shi RZ, Morrissey JM, Rowley JD. Screening and quantification of multiple chromosome translocations in human leukemia. <span><span class="ref-journal">Clin. Chem. </span>2003;<span class="ref-vol">49</span>:1066\xe2\x80\x931073.</span> [<a href="/pubmed/12816902" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin.+Chem.&amp;title=Screening+and+quantification+of+multiple+chromosome+translocations+in+human+leukemia&amp;author=RZ+Shi&amp;author=JM+Morrissey&amp;author=JD+Rowley&amp;volume=49&amp;publication_year=2003&amp;pages=1066-1073&amp;pmid=12816902&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B36">36. <span class="element-citation">Nasedkina TV, Zharinov VS, Isaeva EA, Mityaeva ON, Yurasov RN, Surzhikov SA, Turigin AY, Rubina AY, Karachunskii AI, Gartenhaus RB, et al.  Clinical screening of gene rearrangements in childhood leukemia by using a multiplex polymerase chain reaction-microarray approach. <span><span class="ref-journal">Clin. Cancer Res. </span>2003;<span class="ref-vol">9</span>:5620\xe2\x80\x935629.</span> [<a href="/pubmed/14654544" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin.+Cancer+Res.&amp;title=Clinical+screening+of+gene+rearrangements+in+childhood+leukemia+by+using+a+multiplex+polymerase+chain+reaction-microarray+approach&amp;author=TV+Nasedkina&amp;author=VS+Zharinov&amp;author=EA+Isaeva&amp;author=ON+Mityaeva&amp;author=RN+Yurasov&amp;volume=9&amp;publication_year=2003&amp;pages=5620-5629&amp;pmid=14654544&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B37">37. <span class="element-citation">Zhang QY, Garner K, Viswanatha DS. Rapid detection of leukemia-associated translocation fusion genes using a novel combined RT-PCR and flow cytometric method. <span><span class="ref-journal">Leukemia. </span>2002;<span class="ref-vol">16</span>:144\xe2\x80\x93149.</span> [<a href="/pubmed/11840274" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=Rapid+detection+of+leukemia-associated+translocation+fusion+genes+using+a+novel+combined+RT-PCR+and+flow+cytometric+method&amp;author=QY+Zhang&amp;author=K+Garner&amp;author=DS+Viswanatha&amp;volume=16&amp;publication_year=2002&amp;pages=144-149&amp;pmid=11840274&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B38">38. <span class="element-citation">Nasedkina T, Domer P, Zharinov V, Hoberg J, Lysov Y, Mirzabekov A. Identification of chromosomal translocations in leukemias by hybridization with oligonucleotide microarrays. <span><span class="ref-journal">Haematologica. </span>2002;<span class="ref-vol">87</span>:363\xe2\x80\x93372.</span> [<a href="/pubmed/11940480" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Haematologica&amp;title=Identification+of+chromosomal+translocations+in+leukemias+by+hybridization+with+oligonucleotide+microarrays&amp;author=T+Nasedkina&amp;author=P+Domer&amp;author=V+Zharinov&amp;author=J+Hoberg&amp;author=Y+Lysov&amp;volume=87&amp;publication_year=2002&amp;pages=363-372&amp;pmid=11940480&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B39">39. <span class="element-citation">Maroc N, Morel A, Beillard E, De La Chapelle AL, Fund X, Mozziconacci MJ, Dupont M, Cayuela JM, Gabert J, Koki A, et al.  A diagnostic biochip for the comprehensive analysis of MLL translocations in acute leukemia. <span><span class="ref-journal">Leukemia. </span>2004;<span class="ref-vol">18</span>:1522\xe2\x80\x931530.</span> [<a href="/pubmed/15322560" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=A+diagnostic+biochip+for+the+comprehensive+analysis+of+MLL+translocations+in+acute+leukemia&amp;author=N+Maroc&amp;author=A+Morel&amp;author=E+Beillard&amp;author=AL+De+La+Chapelle&amp;author=X+Fund&amp;volume=18&amp;publication_year=2004&amp;pages=1522-1530&amp;pmid=15322560&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B40">40. <span class="element-citation">de Alava E, Kawai A, Healey JH, Fligman I, Meyers PA, Huvos AG, Gerald WL, Jhanwar SC, Argani P, Antonescu CR, et al.  EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing\'s sarcoma. <span><span class="ref-journal">J. Clin. Oncol. </span>1998;<span class="ref-vol">16</span>:1248\xe2\x80\x931255.</span> [<a href="/pubmed/9552022" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Clin.+Oncol.&amp;title=EWS-FLI1+fusion+transcript+structure+is+an+independent+determinant+of+prognosis+in+Ewing\'s+sarcoma&amp;author=E+de+Alava&amp;author=A+Kawai&amp;author=JH+Healey&amp;author=I+Fligman&amp;author=PA+Meyers&amp;volume=16&amp;publication_year=1998&amp;pages=1248-1255&amp;pmid=9552022&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B41">41. <span class="element-citation">Lin PP, Brody RI, Hamelin AC, Bradner JE, Healey JH, Ladanyi M. Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing\'s sarcoma. <span><span class="ref-journal">Cancer Res. </span>1999;<span class="ref-vol">59</span>:1428\xe2\x80\x931432.</span> [<a href="/pubmed/10197607" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res.&amp;title=Differential+transactivation+by+alternative+EWS-FLI1+fusion+proteins+correlates+with+clinical+heterogeneity+in+Ewing\'s+sarcoma&amp;author=PP+Lin&amp;author=RI+Brody&amp;author=AC+Hamelin&amp;author=JE+Bradner&amp;author=JH+Healey&amp;volume=59&amp;publication_year=1999&amp;pages=1428-1432&amp;pmid=10197607&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B42">42. <span class="element-citation">Saramaki OR, Harjula AE, Martikainen PM, Vessella RL, Tammela TL, Visakorpi T. TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis. <span><span class="ref-journal">Clin. Cancer Res. </span>2008;<span class="ref-vol">14</span>:3395\xe2\x80\x933400.</span> [<a href="/pubmed/18519769" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin.+Cancer+Res.&amp;title=TMPRSS2:ERG+fusion+identifies+a+subgroup+of+prostate+cancers+with+a+favorable+prognosis&amp;author=OR+Saramaki&amp;author=AE+Harjula&amp;author=PM+Martikainen&amp;author=RL+Vessella&amp;author=TL+Tammela&amp;volume=14&amp;publication_year=2008&amp;pages=3395-3400&amp;pmid=18519769&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B43">43. <span class="element-citation">Szczepanski T. Why and how to quantify minimal residual disease in acute lymphoblastic leukemia? <span><span class="ref-journal">Leukemia. </span>2007;<span class="ref-vol">21</span>:622\xe2\x80\x93626.</span> [<a href="/pubmed/17301806" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=Why+and+how+to+quantify+minimal+residual+disease+in+acute+lymphoblastic+leukemia?&amp;author=T+Szczepanski&amp;volume=21&amp;publication_year=2007&amp;pages=622-626&amp;pmid=17301806&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B44">44. <span class="element-citation">Smit F, Verhaegh GW, Schalken JA. The TMPRSS2-ERG fusion gene can be found in urinary sediments after DRE. <span><span class="ref-journal">Eur. Urol. Suppl. </span>2006;<span class="ref-vol">5</span>:787\xe2\x80\x93787.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur.+Urol.+Suppl.&amp;title=The+TMPRSS2-ERG+fusion+gene+can+be+found+in+urinary+sediments+after+DRE&amp;author=F+Smit&amp;author=GW+Verhaegh&amp;author=JA+Schalken&amp;volume=5&amp;publication_year=2006&amp;pages=787-787&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B45">45. <span class="element-citation">Bradford TJ, Tomlins SA, Wang X, Chinnaiyan AM. Molecular markers of prostate cancer. <span><span class="ref-journal">Urol. Oncol. </span>2006;<span class="ref-vol">24</span>:538\xe2\x80\x93551.</span> [<a href="/pubmed/17138135" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Urol.+Oncol.&amp;title=Molecular+markers+of+prostate+cancer&amp;author=TJ+Bradford&amp;author=SA+Tomlins&amp;author=X+Wang&amp;author=AM+Chinnaiyan&amp;volume=24&amp;publication_year=2006&amp;pages=538-551&amp;pmid=17138135&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B46">46. <span class="element-citation">Jordan BR. DNA microarrays in the clinic: how soon, how extensively? <span><span class="ref-journal">Bioessays. </span>2007;<span class="ref-vol">29</span>:699\xe2\x80\x93705.</span> [<a href="/pubmed/17563090" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioessays&amp;title=DNA+microarrays+in+the+clinic:+how+soon,+how+extensively?&amp;author=BR+Jordan&amp;volume=29&amp;publication_year=2007&amp;pages=699-705&amp;pmid=17563090&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2582611&amp;issue-id=173577&amp;journal-id=4&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">Nucleic Acids Research</span> are provided here courtesy of <strong>Oxford University Press</strong></div></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2582611/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2582611/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2582611/pdf/gkn585.pdf">PDF (1.7M)</a></li> | <li><a href="#" data-citationid="PMC2582611" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2582611%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2582611%2F&amp;text=A%20sensitive%20array-based%20assay%20for%20identifying%20multiple%20TMPRSS2%3AERG%20fusion%20gene%20variants"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2582611%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="18794177" data-aiid="2582611" data-aid="2582611" data-iid="173577" data-domainid="4" data-domain="nar" data-accid="PMC2582611" data-md5="662641b8074d433240a391c5bbf3870a"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T09:57:35-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc101&amp;ncbi_phid=8A1A776BE99AA3E10000000007AA07A8&amp;ncbi_session=8A1A776BE99B5CE1_1962SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2582611%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nar&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2582611/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1A776BE99B5CE1_1962SID /projects/PMC/PMCViewer@4.46 ptpmc101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'